Threepipe On Board For Flexiseq Push

Pro Bono Bio has appointed Threepipe to support with the launch of the brand’s FLEXISEQ product, a new drug-free gel to relieve pain and stiffness associated with osteoarthritis.

As part of the deal, Threepipe will aim to highlight the lifestyle benefits that FLEXISEQ can bring to the UK’s nine million osteoarthritis sufferers.

The brand works with a number of professional clubs including Leicester Tigers and Saracens and elite athletes including Saracens, England and British & Irish Lions rugby player, Brad Barritt (pictured above).

Threepipe will develop digitally led integrated campaigns across earned, owned and paid media and will oversee the management of the brand’s social media channels, which will be key to building product advocacy. 

Produced by the nano-physical medical devices company, FLEXISEQ launched into the UK market earlier this year after successful clinical trials and has also received positive responses from Arthritis Research UK.

Jim Hawker, co-founder, Threepipe: ‘It’s not very often that a genuinely scientific breakthrough non-prescription medical product comes to the market and it’s exciting to be on board to help the brand reach its full potential in the UK.’

Mark Oldacre, regional commercial director, N. Europe, Pro Bono Bio added: ‘Threepipe’s ability to run an effective press office as well as maximise the digital opportunity around our brand was key to them being appointed. We loved their enthusiasm for the brand and their creative thoughts about how to drive awareness amongst key audience groups.’